Update in Neuro-Oncology

CME

Advertisement

Update in Neuro-Oncology is a three day, live stream Harvard Medical School accredited CME course designed to provide national and international audiences with a comprehensive review of the diagnosis and management of adult and pediatric patients with primary and metastatic brain and spinal cord tumors and neurologic complications of cancer.

On the agenda:

  • Keynote: Targeted Therapies for Brain Tumors
  • WHO Classification for Pediatric CNS Tumors
  • Embryonal Tumors
  • Pediatric Low-Grade and High-Grade Gliomas
  • Choroid Plexus Tumors
  • Pineal Tumors
  • Germ Cell Tumors
  • Phakomatoses
  • Keynote: Metabolic Vulnerabilities in IDH Mutant Cancer
  • Advances in Surgery, Imaging and Radiation for Brain Tumors
  • WHO Classification for Adult Gliomas
  • Astrocytoma and Oligodendroglioma, IDH-Mutant
  • Glioblastoma, IDH-Wildtype
  • Meningeal Tumors
  • CNS Lymphomas
  • Palliative Neuro-Oncology
  • Keynote: Neural Control of Cancer
  • Metastases to the Brain, Meninges, Epidural Space and Spinal Cord
  • Paraneoplastic Neurological Syndromes
  • Seizures, Strokes, and CNS Infections in Cancer Patients
  • Neurological Complications of Cancer Therapy
12.25 AMA PRA Category 1 Credits™ - maximum

Date

August 4-6, 2021

Location

Virtual Conference

Email

ceprograms@hms.harvard.edu

Website

cmeregistration.hms.harvard.edu/events/update-in-neuro-oncology/event-summary-77642ecdb7ba450e8b0365ce1256a411.aspx/

Advertisement